• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估行政数据用于诊断妊娠糖尿病的有效性。

Assessment of the Validity of Administrative Data for Gestational Diabetes Ascertainment.

机构信息

Diabetes Unit, Massachusetts General Hospital, Boston, MA (Ms Hsu and Drs Selen and Powe); Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA (Ms Hsu and Dr Powe).

Diabetes Unit, Massachusetts General Hospital, Boston, MA (Ms Hsu and Drs Selen and Powe); Harvard Medical School, Boston, MA (Drs Selen, James, Camargo, Kaimal, and Powe).

出版信息

Am J Obstet Gynecol MFM. 2023 Feb;5(2):100814. doi: 10.1016/j.ajogmf.2022.100814. Epub 2022 Nov 15.

DOI:10.1016/j.ajogmf.2022.100814
PMID:36396038
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10071626/
Abstract

BACKGROUND

Administrative data, including International Classification of Diseases codes and birth certificate records, are often used for retrospective gestational diabetes research investigations to describe associations of gestational diabetes with perinatal complications and long-term outcomes, and to determine gestational diabetes prevalence. Research investigating the validity of using International Classification of Diseases codes and birth certificates for gestational diabetes ascertainment shows varying degrees of reliability.

OBJECTIVE

This study aimed to evaluate the accuracy of both International Classification of Diseases codes and birth certificate diagnosis for gestational diabetes ascertainment in a large hospital-based cohort of pregnant individuals, using laboratory criteria for gestational diabetes mellitus as the reference.

STUDY DESIGN

We studied individuals who received prenatal care at an academic hospital and affiliated community health centers between 1998 and 2016. In the setting of universal 2-step screening for gestational diabetes, pregnant individuals were classified as having gestational diabetes if ≥2 oral glucose tolerance test values met or exceeded National Diabetes Data Group thresholds. We calculated the sensitivity, specificity, positive predictive value, and negative predictive value for International Classification of Diseases code and birth certificate ascertainment of gestational diabetes, and their exact binomial 95% confidence intervals.

RESULTS

In a cohort of 51,059 pregnancies with complete glucose screening, 1303 (2.6%) met National Diabetes Data Group laboratory criteria for gestational diabetes. Gestational diabetes International Classification of Diseases codes had moderate sensitivity of 70.5% (95% confidence interval, 67.9-72.9), high specificity of 99.3% (95% confidence interval, 99.3-99.4), a positive predictive value of 73.3% (95% confidence interval, 70.8-75.8), and a negative predictive value of 99.2% (95% confidence interval, 99.1-99.3). In the 46,512 pregnancies linked to birth certificate data, birth certificate diagnosis had moderate sensitivity (66.3% [95% confidence interval, 63.6-69.0]), high specificity (98.9% [95% confidence interval, 98.8-99.0]), moderate positive predictive value (62.1% [95% confidence interval, 59.8-64.4]), and high negative predictive value (99.1% [95% confidence interval, 99.0-99.2]).

CONCLUSION

Ascertainment of gestational diabetes using administrative data, including International Classification of Diseases codes or birth certificates, has moderate sensitivity, moderate positive predictive value, high specificity, and high negative predictive value. Our findings provide context for interpreting the validity of studies that depend on administrative data for ascertainment of gestational diabetes and comparing them with prospective studies that use laboratory-based gestational diabetes criteria.

摘要

背景

行政数据,包括国际疾病分类代码和出生证明记录,常用于回顾性妊娠期糖尿病研究调查,以描述妊娠期糖尿病与围产期并发症和长期结局的关联,并确定妊娠期糖尿病的患病率。研究表明,使用国际疾病分类代码和出生证明来确定妊娠期糖尿病的准确性存在一定程度的可靠性。

目的

本研究旨在评估在一个大型基于医院的孕妇队列中,使用实验室标准确定妊娠期糖尿病的国际疾病分类代码和出生证明的准确性。

研究设计

我们研究了 1998 年至 2016 年期间在学术医院和附属社区卫生中心接受产前护理的个体。在普遍进行两步筛查的情况下,对于妊娠期糖尿病,如果≥2 个口服葡萄糖耐量试验值符合或超过国家糖尿病数据组的标准,则将个体归类为患有妊娠期糖尿病。我们计算了国际疾病分类代码和出生证明确定妊娠期糖尿病的灵敏度、特异性、阳性预测值和阴性预测值,并计算了它们确切的二项式 95%置信区间。

结果

在一项包含 51059 例完整葡萄糖筛查的队列中,有 1303 例(2.6%)符合国家糖尿病数据组实验室标准的妊娠期糖尿病。妊娠期糖尿病国际疾病分类代码的灵敏度为 70.5%(95%置信区间,67.9-72.9),特异性为 99.3%(95%置信区间,99.3-99.4),阳性预测值为 73.3%(95%置信区间,70.8-75.8),阴性预测值为 99.2%(95%置信区间,99.1-99.3)。在与出生证明数据相关联的 46512 例妊娠中,出生证明诊断的灵敏度为 66.3%(95%置信区间,63.6-69.0%),特异性为 98.9%(95%置信区间,98.8-99.0%),阳性预测值为 62.1%(95%置信区间,59.8-64.4%),阴性预测值为 99.1%(95%置信区间,99.0-99.2%)。

结论

使用行政数据(包括国际疾病分类代码或出生证明)确定妊娠期糖尿病的方法具有中等的灵敏度、中等的阳性预测值、高特异性和高阴性预测值。我们的研究结果为解释基于实验室标准的前瞻性研究与依赖行政数据确定妊娠期糖尿病的研究之间的有效性提供了背景,并为它们提供了比较。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1af/10071626/d0e956705b55/nihms-1866922-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1af/10071626/d0e956705b55/nihms-1866922-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1af/10071626/d0e956705b55/nihms-1866922-f0001.jpg

相似文献

1
Assessment of the Validity of Administrative Data for Gestational Diabetes Ascertainment.评估行政数据用于诊断妊娠糖尿病的有效性。
Am J Obstet Gynecol MFM. 2023 Feb;5(2):100814. doi: 10.1016/j.ajogmf.2022.100814. Epub 2022 Nov 15.
2
Screening and diagnosing gestational diabetes mellitus.妊娠期糖尿病的筛查与诊断
Evid Rep Technol Assess (Full Rep). 2012 Oct(210):1-327.
3
Validation of administrative and clinical case definitions for gestational diabetes mellitus against laboratory results.基于实验室检测结果对妊娠期糖尿病的管理和临床病例定义进行验证。
Diabet Med. 2017 Jun;34(6):781-785. doi: 10.1111/dme.13271. Epub 2016 Nov 16.
4
Validation of administrative data case definitions for gestational diabetes mellitus.妊娠期糖尿病管理数据病例定义的验证
Diabet Med. 2017 Jan;34(1):51-55. doi: 10.1111/dme.13030. Epub 2015 Dec 24.
5
Screening for gestational diabetes mellitus in pregnant females.孕妇妊娠糖尿病的筛查
Saudi Med J. 2000 Feb;21(2):155-60.
6
Oral glucose tolerance testing at gestational weeks < or =16 could predict or exclude subsequent gestational diabetes mellitus during the current pregnancy in high risk group.孕16周及以内进行口服葡萄糖耐量试验,可预测或排除高危组孕妇当前孕期后续发生的妊娠期糖尿病。
Eur J Obstet Gynecol Reprod Biol. 2005 Jul 1;121(1):51-5. doi: 10.1016/j.ejogrb.2004.11.006.
7
Utilization of International Association of Diabetes and Pregnancy Study Groups criteria vs. a two-step approach to screening for gestational diabetes mellitus in Chinese women with twin pregnancies.国际糖尿病与妊娠研究组标准在中国双胎妊娠女性中用于筛查妊娠期糖尿病与两步法筛查的比较
Diabet Med. 2015 Mar;32(3):367-73. doi: 10.1111/dme.12636. Epub 2014 Dec 12.
8
Does the 1-step method of gestational diabetes mellitus screening improve pregnancy outcomes?1 步筛查法用于妊娠期糖尿病筛查能否改善妊娠结局?
Am J Obstet Gynecol MFM. 2020 Nov;2(4):100199. doi: 10.1016/j.ajogmf.2020.100199. Epub 2020 Aug 17.
9
Screening for gestational diabetes mellitus based on different risk profiles and settings for improving maternal and infant health.基于不同风险特征和环境进行妊娠期糖尿病筛查以改善母婴健康。
Cochrane Database Syst Rev. 2017 Aug 3;8(8):CD007222. doi: 10.1002/14651858.CD007222.pub4.
10
Prevalence of gestational diabetes mellitus based on various screening strategies in western Kenya: a prospective comparison of point of care diagnostic methods.基于肯尼亚西部各种筛查策略的妊娠糖尿病患病率:即时护理诊断方法的前瞻性比较
BMC Pregnancy Childbirth. 2017 Jul 14;17(1):226. doi: 10.1186/s12884-017-1415-4.

引用本文的文献

1
Maternal coronary heart disease and mortality following hypertensive disorders of pregnancy and/or diabetes.妊娠高血压疾病和/或糖尿病后的孕产妇冠心病及死亡率
Cardiovasc Diabetol. 2025 Jul 11;24(1):282. doi: 10.1186/s12933-025-02811-8.
2
Hematologic dynamics during pregnancy and their association with obstetric complications: a retrospective cohort study.孕期血液动力学及其与产科并发症的关联:一项回顾性队列研究。
medRxiv. 2025 Feb 14:2025.02.13.25322250. doi: 10.1101/2025.02.13.25322250.
3
Association of Prepregnancy Cardiometabolic Factors With Gestational Diabetes Among Asian Populations in the United States.美国亚洲人群孕前心脏代谢因素与妊娠期糖尿病的关联
JACC Asia. 2024 Sep 24;4(11):842-852. doi: 10.1016/j.jacasi.2024.07.010. eCollection 2024 Nov.
4
Risk of Neonatal Hypoglycemia in Infants of Mothers With Gestational Glucose Intolerance.母亲妊娠期糖代谢异常与新生儿低血糖风险的相关性。
Diabetes Care. 2024 Jul 1;47(7):1194-1201. doi: 10.2337/dc23-2239.
5
Health Service Use and Costs During Pregnancy Among Privately Insured Individuals With Congenital Heart Disease.先天性心脏病患者的私人保险健康服务使用情况和妊娠期间的费用。
JAMA Netw Open. 2024 May 1;7(5):e2410763. doi: 10.1001/jamanetworkopen.2024.10763.
6
The simultaneous occurrence of gestational diabetes and hypertensive disorders of pregnancy affects fetal growth and neonatal morbidity.妊娠糖尿病与妊娠高血压疾病同时发生会影响胎儿生长和新生儿发病率。
Am J Obstet Gynecol. 2024 Nov;231(5):548.e1-548.e21. doi: 10.1016/j.ajog.2024.03.009. Epub 2024 Mar 14.
7
Prevalence of gestational diabetes in the United States and Canada: a systematic review and meta-analysis.妊娠期糖尿病在美国和加拿大的流行情况:系统评价和荟萃分析。
BMC Pregnancy Childbirth. 2024 Mar 15;24(1):204. doi: 10.1186/s12884-024-06378-2.
8
Gestational Glucose Intolerance and Birth Weight-Related Complications.妊娠期葡萄糖不耐受与出生体重相关并发症。
Obstet Gynecol. 2023 Sep 1;142(3):594-602. doi: 10.1097/AOG.0000000000005278. Epub 2023 Aug 3.
9
Rural-urban disparities in pregestational and gestational diabetes in pregnancy: Serial, cross-sectional analysis of over 12 million pregnancies.城乡妊娠前和妊娠期间糖尿病的差异:超过 1200 万例妊娠的连续、横断面分析。
BJOG. 2024 Jan;131(1):26-35. doi: 10.1111/1471-0528.17587. Epub 2023 Jun 27.

本文引用的文献

1
Trends in Gestational Diabetes at First Live Birth by Race and Ethnicity in the US, 2011-2019.美国 2011-2019 年按种族和民族划分的首次活产时妊娠糖尿病趋势。
JAMA. 2021 Aug 17;326(7):660-669. doi: 10.1001/jama.2021.7217.
2
Validation of ICD-10 Codes for Gestational and Pregestational Diabetes During Pregnancy in a Large, Public Hospital.在一家大型公立医院中验证妊娠和孕前糖尿病的 ICD-10 编码。
Epidemiology. 2021 Mar 1;32(2):277-281. doi: 10.1097/EDE.0000000000001311.
3
Assessing the Quality of Medical and Health Data From the 2003 Birth Certificate Revision: Results From New York City.评估2003年出生证明修订版中的医疗卫生数据质量:纽约市的结果
Natl Vital Stat Rep. 2019 Jun;68(8):1-20.
4
Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis.已知有妊娠糖尿病史的女性发展为 2 型糖尿病的情况:系统评价和荟萃分析。
BMJ. 2020 May 13;369:m1361. doi: 10.1136/bmj.m1361.
5
Defining maternal obesity in studies of birth outcomes: Comparing ICD-9 codes at delivery and measures on the birth certificate.在研究分娩结局的研究中定义肥胖的母亲:比较分娩时的 ICD-9 编码和出生证明上的措施。
Paediatr Perinat Epidemiol. 2020 Sep;34(5):618-627. doi: 10.1111/ppe.12667. Epub 2020 Mar 17.
6
Prevalence of gestational diabetes according to commonly used data sources: an observational study.基于常用数据源的妊娠期糖尿病患病率:一项观察性研究。
BMC Pregnancy Childbirth. 2019 Oct 11;19(1):349. doi: 10.1186/s12884-019-2521-2.
7
Validity of type 2 diabetes diagnosis in a population-based electronic health record database.基于人群的电子健康记录数据库中2型糖尿病诊断的有效性
BMC Med Inform Decis Mak. 2017 Apr 8;17(1):34. doi: 10.1186/s12911-017-0439-z.
8
Patterns of gestational diabetes diagnosis inside and outside of clinical guidelines.临床指南内外的妊娠期糖尿病诊断模式
BMC Pregnancy Childbirth. 2017 Jan 6;17(1):11. doi: 10.1186/s12884-016-1191-6.
9
Validation of administrative and clinical case definitions for gestational diabetes mellitus against laboratory results.基于实验室检测结果对妊娠期糖尿病的管理和临床病例定义进行验证。
Diabet Med. 2017 Jun;34(6):781-785. doi: 10.1111/dme.13271. Epub 2016 Nov 16.
10
Gestational diabetes in the United States: temporal changes in prevalence rates between 1979 and 2010.美国的妊娠期糖尿病:1979 年至 2010 年期间患病率的时间变化。
BJOG. 2017 Apr;124(5):804-813. doi: 10.1111/1471-0528.14236. Epub 2016 Aug 11.